viernes, 10 de abril de 2015

CDC Hepatitis Updates - Webinar on Hepatitis C Prevention for People Who Inject Drugs

CDC Hepatitis Updates - Webinar on Hepatitis C Prevention for People Who Inject Drugs



Viral Hepatitis Updates from CDC
Register for Webinar on Hepatitis C Prevention for People Who Inject Drugs
The HHS Office of HIV/AIDS and Infectious Disease Policy will host a webinar, Hepatitis C Prevention Opportunities among People Who Inject Drugs (PWID) – Confronting the Growing Epidemic, on Tuesday, April 28, 2015 from 1:00-2:00 PM (ET)Speakers will discuss the trends and the changing landscape of HCV among PWID, key findings from CDC investigations, opportunities and challenges in HCV prevention, best practices and model programs, and evidence-based HCV prevention messages and activities.

Hepatitis C & Injection Drug Use Fact Sheet CDC has developed a fact sheet on Hepatitis C and injection drug use. The fact sheet includes an overview of hepatitis C including symptoms, testing, transmission, prevention, treatment, and reinfection.

A Guide to Comprehensive Hepatitis C Counseling and Testing
CDC has developed two professional resources in support of hepatitis C counseling and testing in public health and primary care settings. Manual for use is public health settings [PDF - 60 pages]

African Immigrants at Increased Risk for Hepatitis BUp to 1.4 million people in the U.S. are chronically infected with the hepatitis B virus. One of the populations disproportionately affected by this disease is the African immigrant community, which has infection rates of approximately 10 percent. Over the last 20 years the African immigrant population has more than doubled in size. This growth, along with advances in our understanding and treatment of HBV make this a critical time to raise awareness among healthcare providers about the rates of chronic hepatitis B among immigrants, potential consequences of the disease, and opportunities for prevention, diagnosis, and treatment. http://blog.aids.gov/2015/04/african-immigrants-at-increased-risk-for-hepatitis-b.html

No hay comentarios:

Publicar un comentario